These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 35933554)
21. Clinical implications of incomplete repair parameters for rat spinal cord: the feasibility of large doses per fraction in PDR and HDR brachytherapy. Pop LA; Millar WT; Visser AG; van der Kogel AJ Int J Radiat Oncol Biol Phys; 2001 Sep; 51(1):215-26. PubMed ID: 11516872 [TBL] [Abstract][Full Text] [Related]
22. A simple method of obtaining equivalent doses for use in HDR brachytherapy. Nag S; Gupta N Int J Radiat Oncol Biol Phys; 2000 Jan; 46(2):507-13. PubMed ID: 10661360 [TBL] [Abstract][Full Text] [Related]
23. Effect of intratumor heterogeneity on BED for hypofractionated dose regimens. Kuperman VY Med Phys; 2019 Oct; 46(10):4690-4698. PubMed ID: 31257607 [TBL] [Abstract][Full Text] [Related]
24. Conversion and validation of rectal constraints for prostate carcinoma receiving hypofractionated carbon-ion radiotherapy with a local effect model. Wang W; Li P; Sheng Y; Huang Z; Zhao J; Hong Z; Shahnazi K; Jiang GL; Zhang Q Radiat Oncol; 2021 Apr; 16(1):72. PubMed ID: 33849589 [TBL] [Abstract][Full Text] [Related]
25. Analysis of a large number of clinical studies for breast cancer radiotherapy: estimation of radiobiological parameters for treatment planning. Guerrero M; Li XA Phys Med Biol; 2003 Oct; 48(20):3307-26. PubMed ID: 14620060 [TBL] [Abstract][Full Text] [Related]
26. The linear-quadratic model and most other common radiobiological models result in similar predictions of time-dose relationships. Brenner DJ; Hlatky LR; Hahnfeldt PJ; Huang Y; Sachs RK Radiat Res; 1998 Jul; 150(1):83-91. PubMed ID: 9650605 [TBL] [Abstract][Full Text] [Related]
27. Comparison of Tumor Control and Skin Damage in a Mouse Model after Ultra-High Dose Rate Irradiation and Conventional Irradiation. Duval KEA; Aulwes E; Zhang R; Rahman M; Ashraf MR; Sloop A; Sunnerberg J; Williams BB; Cao X; Bruza P; Kheirollah A; Tavakkoli A; Jarvis LA; Schaner PE; Swartz HM; Gladstone DJ; Pogue BW; Hoopes PJ Radiat Res; 2023 Sep; 200(3):223-231. PubMed ID: 37590482 [TBL] [Abstract][Full Text] [Related]
28. Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial. Widmark A; Gunnlaugsson A; Beckman L; Thellenberg-Karlsson C; Hoyer M; Lagerlund M; Kindblom J; Ginman C; Johansson B; Björnlinger K; Seke M; Agrup M; Fransson P; Tavelin B; Norman D; Zackrisson B; Anderson H; Kjellén E; Franzén L; Nilsson P Lancet; 2019 Aug; 394(10196):385-395. PubMed ID: 31227373 [TBL] [Abstract][Full Text] [Related]
29. Estimation of errors associated with use of linear-quadratic formalism for evaluation of biologic equivalence between single and hypofractionated radiation doses: an in vitro study. Iwata H; Shibamoto Y; Murata R; Tomita N; Ayakawa S; Ogino H; Ito M Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):482-8. PubMed ID: 19735872 [TBL] [Abstract][Full Text] [Related]
30. Ten-Fraction Stereotactic Radiosurgery With Different Gross Tumor Doses and Inhomogeneities for Brain Metastasis of >10 cc: Treatment Responses Suggesting Suitable Biological Effective Dose Formula for Single and 10 Fractions. Ohtakara K; Nakabayashi K; Suzuki K Cureus; 2023 Feb; 15(2):e34636. PubMed ID: 36895545 [TBL] [Abstract][Full Text] [Related]
31. Hypofractionation: what does it mean for prostate cancer treatment? Liao Y; Joiner M; Huang Y; Burmeister J Int J Radiat Oncol Biol Phys; 2010 Jan; 76(1):260-8. PubMed ID: 19879698 [TBL] [Abstract][Full Text] [Related]
32. The linear-quadratic model is an appropriate methodology for determining isoeffective doses at large doses per fraction. Brenner DJ Semin Radiat Oncol; 2008 Oct; 18(4):234-9. PubMed ID: 18725109 [TBL] [Abstract][Full Text] [Related]
33. Optimal hypofractionated radiation therapy schemes for early-stage hepatocellular carcinoma. Liu F; Brown DR; Munley MT Radiother Oncol; 2024 May; 194():110223. PubMed ID: 38467342 [TBL] [Abstract][Full Text] [Related]
34. Utility of normal tissue-to-tumor α/β ratio when evaluating isodoses of isoeffective radiation therapy treatment plans. Gay HA; Jin JY; Chang AJ; Ten Haken RK Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):e81-7. PubMed ID: 23141886 [TBL] [Abstract][Full Text] [Related]
36. High-throughput, low-cost FLASH: irradiation of Drosophila melanogaster with low-energy X-rays using time structures spanning conventional and ultrahigh dose rates. Hart A; Dudzic JP; Clarke JW; Eby J; Perlman SJ; Bazalova-Carter M J Radiat Res; 2024 Oct; ():. PubMed ID: 39422537 [TBL] [Abstract][Full Text] [Related]
37. Comparable Long-Term Tumor Control for Hypofractionated FLASH Versus Conventional Radiation Therapy in an Immunocompetent Rat Glioma Model. Konradsson E; Liljedahl E; Gustafsson E; Adrian G; Beyer S; Ilaahi SE; Petersson K; Ceberg C; Nittby Redebrandt H Adv Radiat Oncol; 2022; 7(6):101011. PubMed ID: 36092986 [TBL] [Abstract][Full Text] [Related]
38. Hybrid ultra-high and conventional dose rate treatments with electrons and photons for the clinical transfer of FLASH-RT to deep-seated targets: A treatment planning study. Böhlen TT; Zeverino M; Germond JF; Kinj R; Schiappacasse L; Bochud F; Herrera F; Bourhis J; Moeckli R Radiother Oncol; 2024 Oct; 201():110576. PubMed ID: 39395673 [TBL] [Abstract][Full Text] [Related]
39. Impact of dose size in single fraction spatially fractionated (grid) radiotherapy for melanoma. Zhang H; Zhong H; Barth RF; Cao M; Das IJ Med Phys; 2014 Feb; 41(2):021727. PubMed ID: 24506618 [TBL] [Abstract][Full Text] [Related]
40. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity. Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]